Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (361-370 of 455) with videos related to

Pageof 46
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 3, 2016
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patientsBrigitte Rack, Julia Jückstock, Elisabeth Trapp, et al.
The Lancet. Respiratory Medicine|March 19, 2022
Effects of SARS-CoV-2 on prenatal lung growth assessed by fetal MRISophia Stoecklein, Vanessa Koliogiannis, Tobias Prester, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 1, 2026
A Mobile Exhibition to Advance Cancer Prevention Awareness: A Cross-Sectional Evaluation Using the RE-AIM FrameworkTheres Fey, Theresa Herzig, Irina Rupp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 16, 2015
The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT StudyChristina Fotopoulou, Jalid Sehouli, Nina Ewald-Riegler, et al.
BMC Cancer|April 18, 2018
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancerAnna Semmlinger, Viktoria von Schoenfeldt, Verena Wolf, et al.
International Journal of Cancer|April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortiumEva Obermayr, Thomas Mohr, Eva Schuster, et al.
International Journal of Cancer|May 6, 2024
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortiumGesa Fromhage, Eva Obermayr, Natalia Bednarz-Knoll, et al.
Journal of Cancer Research and Clinical Oncology|September 6, 2022
High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancerSusanne Beyer, Lena Müller, Sophie Mitter, et al.
BMC Cancer|September 19, 2013
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortiumAnna Bachmayr-Heyda, Stefanie Aust, Georg Heinze, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 1, 2015
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD studyMani Nassir, Jun Guan, Hrvoje Luketina, et al.
Pageof 46

Showing results (361-370 of 455) with videos related to

Sort By:
Pageof 46
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 3, 2016
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patientsBrigitte Rack, Julia Jückstock, Elisabeth Trapp, et al.
The Lancet. Respiratory Medicine|March 19, 2022
Effects of SARS-CoV-2 on prenatal lung growth assessed by fetal MRISophia Stoecklein, Vanessa Koliogiannis, Tobias Prester, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 1, 2026
A Mobile Exhibition to Advance Cancer Prevention Awareness: A Cross-Sectional Evaluation Using the RE-AIM FrameworkTheres Fey, Theresa Herzig, Irina Rupp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 16, 2015
The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT StudyChristina Fotopoulou, Jalid Sehouli, Nina Ewald-Riegler, et al.
BMC Cancer|April 18, 2018
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancerAnna Semmlinger, Viktoria von Schoenfeldt, Verena Wolf, et al.
International Journal of Cancer|April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortiumEva Obermayr, Thomas Mohr, Eva Schuster, et al.
International Journal of Cancer|May 6, 2024
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortiumGesa Fromhage, Eva Obermayr, Natalia Bednarz-Knoll, et al.
Journal of Cancer Research and Clinical Oncology|September 6, 2022
High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancerSusanne Beyer, Lena Müller, Sophie Mitter, et al.
BMC Cancer|September 19, 2013
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortiumAnna Bachmayr-Heyda, Stefanie Aust, Georg Heinze, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 1, 2015
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD studyMani Nassir, Jun Guan, Hrvoje Luketina, et al.
Pageof 46